Concord Biotech Ltd.
|
Nine Months RESULTS
|
|
You can view the
Nine Months Results
for the last 5 years.
Market Cap. (Rs.)
|
16148.56 Cr.
|
P/BV
|
10.15
|
Book Value (Rs.)
|
152.02
|
52 Week High/Low (Rs.)
|
2664/1327
|
FV/ML
|
1/1
|
P/E(X)
|
52.41
|
Bookclosure
|
29/06/2024
|
EPS (Rs.)
|
29.45
|
Div Yield (%)
|
0.57
|
|
(Rs. in Crs.)
Net Sales/Income from operations | 770.20 | 697.97 | 580.58 |
Total Income From Operations | 770.20 | 697.97 | 580.58 |
| | | |
EXPENDITURE | | | |
Consumption of Raw Materials | 184.04 | 128.87 | 123.73 |
Purchase of Traded Goods | 45.67 | 45.29 | 19.24 |
Increase/Decrease in Stocks | -52.70 | -33.80 | -19.40 |
Power & Fuel | 26.44 | 0.00 | 0.00 |
Employees Cost | 99.97 | 89.09 | 81.59 |
Depreciation | 39.76 | 39.87 | 39.85 |
Other Expenses | 150.87 | 171.26 | 161.19 |
Total Expenses | 494.05 | 440.57 | 406.20 |
| | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 276.15 | 257.40 | 174.38 |
Other Income | 35.06 | 22.97 | 23.11 |
P/L Before Interest, Excpt. Items & Tax | 311.21 | 280.36 | 197.49 |
Interest | 0.43 | 2.09 | 3.06 |
P/L Before Exceptional Items & Tax | 310.78 | 278.28 | 194.43 |
P/L Before Tax | 310.78 | 278.28 | 194.43 |
Tax | 79.75 | 70.76 | 49.81 |
P/L After Tax from Ordinary Activities | 231.03 | 207.52 | 144.62 |
Net Profit/Loss For the Period | 231.03 | 207.52 | 144.62 |
Share Of P/L Of Associates | 0.23 | 5.57 | 3.97 |
Net P/L After Minority Interest & Share Of Associates | 231.26 | 213.09 | 148.59 |
| | | |
Equity Share Capital | 10.46 | 10.46 | 10.46 |
EPS Before Extra Ordinary * | | | |
Basic EPS (Rs.) | 22.08 | 20.37 | 14.20 |
Diluted EPS (Rs.) | 22.09 | 20.37 | 14.20 |
EPS After Extra Ordinary * | | | |
Basic EPS (Rs.) | 22.08 | 20.37 | 14.20 |
Diluted EPS (Rs.) | 22.11 | 20.37 | 14.20 |
| | | |
PBITOE Margin (%) | 35.85 | 36.87 | 30.03 |
PBTE Margin (%) | 40.35 | 39.86 | 33.48 |
PBT Margin (%) | 40.35 | 39.86 | 33.48 |
PAT Margin (%) | 29.99 | 29.73 | 24.90 |
PAT After MI And SOA Margin (%) | 30.02 | 30.52 | 25.59 |